Severe pneumonia is one of the clinically common acute and critical illnesses. It refers to not only the common respiratory diseases with pneumonia but also the manifestations of respiratory failure and other systems’ obvious involvement. Common clinical manifestations include fever, cough, sputum, chest pain; if pneumonia is complicated by multiple organ failure, such as respiratory failure, heart failure, coagulopathy, renal failure, shock, etc., the condition is often very critical and often requires treatment and monitoring in the ICU can last for several weeks or longer. Novel coronavirus infected pneumonia may cause acute respiratory distress syndrome, septic shock, difficult-to-correct metabolic acidosis, and blood clotting dysfunction in severe cases, which endanger life and health and require intensive care and treatment.
Common Clinical Treatment
- Drug treatment: antibacterial drugs, glucocorticoids, gamma globulin, and albumin, nutritional support
- Non-drug treatment: monitoring, oxygen therapy, assisted breathing, drainage Generally, the drug should be stopped within 3-5 days after the fever subsides and the main respiratory symptoms are significantly improved. However, the course of treatment varies with different pathogens and the severity of the condition.
Surveillance of Patients with Severe Pneumonia
- Fever care
Severe pneumonia patients are often accompanied by fever, so cooling care is particularly important for them
- Medication care
Patients with severe pneumonia usually receive anti-infective therapy in clinical practice. There are many kinds of medications during the treatment period, and the order of medication needs to be rationally arranged, combined with drug compatibility contraindications. During intravenous drip administration, the rate of administration must be strictly controlled. Nursing staff should strictly monitor vital signs such as pulse, heart rate, and blood pressure during patients’ medication.
- Respiratory care
Severe pneumonia often leads to lung congestion, edema, and other symptoms, increased secretions in the respiratory tract, and patients often have symptoms of dyspnea. For such conditions, patients should be given ultrasonic atomization inhalation to relieve spasm and expectoration and keep breathing smooth. Mechanical ventilation should be given to patients with respiratory failure. When mechanical sputum suction, the action should be gentle to ensure the aseptic operation and avoid infection. On admission, routine blood gas analysis, assessment of respiratory function, and active oxygen therapy should be performed. The saturation of blood samples is maintained at 94%-98% based on nasal catheters or masks. For patients who are at risk of CO2 retention, it can be maintained at around 90%.
Patients with severe pneumonia should always pay attention to measuring pulse, heart rhythm, blood pressure, and other vital signs. Heal Force recommends the IMD12 modular multi-parameter monitor, which is suitable for monitoring applications of severe pneumonia.
IMD12 Modular Multi-parameter Monitor
-12.1-inch full touch screen design, with ultra-thin appearance, easy to move
-With 2 groups of continuous body temperature dynamic monitoring
-With ≥13 kinds of arrhythmia automatic analysis, ≥15 drug concentration analysis, four-channel ST segment analysis, pacing analysis
-Up to 4 breathing measurement modes and optional side-flow end-breathing carbon dioxide, the pumping rate is as low as 50ml/min, suitable for patients of all ages from adults to newborns, no need for traditional dehydration bottles
-Quickly switch between different display interface function keys, with trend coexistence interface, respiratory oxygenation graph interface, large font display interface, standard display interface, full-screen 7-guides, and other display interfaces.
-Night monitoring mode